Skip to content

Medpace Holdings, Inc. MEDP Business Segments — Total direct costs

Similar metrics at other companies

Madrigal Pharmaceuticals, Inc. logo
MDGLReportable Segment — Cost of Sales
$18.12M+742%
Broadridge Financial Solutions logo
BRTotal Reportable Segments — Other direct expenses
$1.32B+8.2%
BioMarin Pharmaceuticals logo
BMRNReportable Segment — Cost of Sales
$195M+28.7%
Lam Research logo
LRCXReportable Segment — Segment Reporting, Cost of Product and Service Sold
$2.84B+20.2%
Roivant Sciences logo
ROIVReportable Segment — Cost of revenues
$320K+56.1%
Madrigal Pharmaceuticals, Inc. logo
MDGLReportable Segment — Cost of Product and Service Sold
$26.85M+495%

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DirectOperatingCosts.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s business segments — total direct costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s business segments — total direct costs?
Medpace Holdings, Inc. (MEDP) reported business segments — total direct costs of $510.28M in Q1 2026.
How has Medpace Holdings, Inc.'s business segments — total direct costs changed year-over-year?
Medpace Holdings, Inc.'s business segments — total direct costs increased by 34.2% year-over-year, from $380.22M to $510.28M.
What is the long-term trend for Medpace Holdings, Inc.'s business segments — total direct costs?
Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s business segments — total direct costs has grown at a 19.9% compound annual growth rate (CAGR), from $1.03B to $1.77B.
What does business segments — total direct costs mean?
The direct expenses incurred to deliver the services provided by this segment.
How do you interpret business segments — total direct costs?
An increase relative to revenue may indicate declining operational efficiency or rising labor costs, while a decrease suggests improved cost management.
How does business segments — total direct costs compare across companies?
Comparable to 'Cost of Services' or 'Cost of Revenue' in other professional services and CRO organizations.